Biotech

All Articles

Galapagos stops briefly CAR-T cell therapy trial over Parkinsonism case

.Galapagos has paused registration in a trial of a BCMA-directed CAR-T cell therapy, pumping the bra...

James Wilson leaving behind Penn to introduce 2 brand new biotechs

.After much more than thirty years, genetics therapy trendsetter James Wilson M.D., Ph.D., is leavin...

3 biotechs make an effort to trump the summer season warm through losing workers

.As biotechs attempt to switch a fresh web page in August, a minimum of three companies have lost st...

venBio lifts $528M for fifth lifestyle scientific researches VC fund

.Professional financial backing company venBio has raised one more half a billion bucks to purchase ...

Otsuka spends $800M for Jnana and also its clinical-stage PKU medication

.Otsuka Pharmaceutical has gotten Boston-based Jnana Rehabs for $800 million so the Japanese biotech...

FibroGen lays off 75% people team as asset fails 2 more tests

.FibroGen is actually substantially reorganizing its company, laying off 75% of its U.S. personnel a...

Tracon winds down full weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has actually chosen to wane procedures weeks after an injectable immune syst...

Ideaya bags option on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M reduction on fallen short epilepsy drug, touts FDA run

.Our experts already understand that Takeda is actually expecting to locate a course to the FDA for ...

VBI Vaccines files for bankruptcy, looks for resource sale

.Immunology biotech VBI Injections is drifting hazardously close to the climax, with strategies to d...